Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 2102 of 6351
-
New drug combo shows promise for Tough-to-Treat lymphoma
Disease control CompletedThis study is researching a combination of 2 experimental drugs, referred to as "study drugs", called odronextamab (also known as REGN1979) and cemiplimab (also known as REGN2810). The study is focused on patients who have relapse/refractory aggressive B-cell lymphoma. The aim of…
Phase 1 • Sponsor: Regeneron Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
Targeted pill takes aim at rare cancer mutations
Disease control OngoingThis phase II MATCH treatment trial evaluates the effectiveness of osimertinib (AZD9291) in treating patients with cancer that has certain genetic changes called EGFR mutations. Osimertinib is in a class of medications called kinase inhibitors. It works by blocking the action of …
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 12:39 UTC
-
Could a blood pressure drug ease Veterans' Post-Concussion headaches?
Symptom relief CompletedThe purpose of this study is to determine if prazosin is more effective than placebo in decreasing frequency, severity, disability, and other negative effects of headaches related to mild traumatic brain injury in Service Members and Veterans.
Phase 1/2 • Sponsor: VA Office of Research and Development • Aim: Symptom relief
Last updated Jun 27, 2026 12:02 UTC
-
Zapping the brain while recalling trauma may ease PTSD
Symptom relief CompletedThe aim of this study is to assess the efficacy in PTSD treatment of concomitant voluntary reactivation of personal traumatic memories with neuromodulation of the right dorsolateral prefrontal cortex using 10Hz rTMS, compared to 1Hz rTMS, during 2 weeks.
Sponsor: University Hospital, Tours • Aim: Symptom relief
Last updated Jun 27, 2026 13:05 UTC
-
New combo therapy shows promise for rare blood cancer in younger patients
Disease control CompletedThe purpose of this study is to: 1. determine the efficiency of EDOCH (etoposide,dexamethasone,doxorubicin, cyclophosphamide and vincristine) alternating with DHAP (cisplatin, cytarabine and dexamethasone) regimen combined with rituximab or not in young mantle cell lymphoma pati…
Phase 4 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
Can a 45-Minute iPad test unlock how CCHS affects the brain?
Knowledge-focused Recruiting nowCongenital central hypoventilation syndrome (CCHS) is a rare disorder of autonomic and respiratory regulation that frequently alters oxygen delivery to the brain. In CCHS, neurocognitive function has been of great concern because of the potential for repeated hypoxemia and hyperc…
Sponsor: Ilya Khaytin • Aim: Knowledge-focused
Last updated Sep 05, 2026 00:00 UTC
-
Robot surgery may cut complications in colorectal cancer operations
Knowledge-focused OngoingThe objective of this research project is to conduct a comparative analysis of short- and long-term outcomes between conventional laparoscopic and robot-assisted resection procedures for colorectal cancer. The analysis will utilize population-based DRG data and clinical cancer re…
Sponsor: Medizinische Hochschule Brandenburg Theodor Fontane • Aim: Knowledge-focused
Last updated Jun 26, 2026 13:35 UTC
-
New eye procedure could stop keratoconus without removing cornea layer
Disease control CompletedThis study investigates the effectiveness and safety of two different corneal cross-linking (CXL) protocols for the management of progressive keratoconus: the accelerated epithelium-off technique (aCXL) and the topography-guided epithelium-on Customized Remodeled Vision (CuRV) pr…
Sponsor: Gemini Eye Clinic • Aim: Disease control
Last updated Jun 26, 2026 16:57 UTC
-
Could your next stem cell recovery happen at home?
Disease control OngoingIn this study, the investigators plan to see what happens when a person receives care in the home setting. They want to find out if caring for a patient who has been treated with an ASCT in the home setting is feasible. They want to find out what effects good and/or bad this will…
Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jul 16, 2026 00:00 UTC
-
Could a simple mouth rinse replace invasive tests for a deadly pneumonia?
Diagnosis CompletedPneumocystis jirovecii pneumonia is a serious and frequent infection in immunocompromised patients, whose evolution is potentially fatal if untreated. It is the most common opportunistic infections classifying patients infected with human immunodeficiency virus (human immunodefic…
Sponsor: Rennes University Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 14:00 UTC
-
Computer coach aims to sharpen therapy for Veterans' depression
Disease control CompletedBackground and Significance: Mental health (MH) providers in VA Community-Based-Outpatient-Clinics (CBOCs) are often located in rural areas and isolated from educational opportunities. Almost half of Veterans now use CBOCs. Studies have shown that the quality of delivery of EBPs …
Sponsor: VA Office of Research and Development • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
A simple probe may reveal the perfect moment to wake up from anesthesia
Knowledge-focused Completed1. An intact pharyngoesophageal reflex is essential to protect the upper airway from aspiration of either mouth contents or regurgitated gastric refluxate. This reflex is essential at protecting the airway in all patients. 2. In patients, while under general anesthesia, it is pos…
Sponsor: University of California, San Francisco • Aim: Knowledge-focused
Last updated Aug 22, 2026 00:00 UTC
-
Nanochitosan paste takes on denture fungal infections
Disease control CompletedThis study is designed to survey the therapeutic effect of a low molecular weight 5% nanochitosan paste against oral candidosis (denture stomatitis) and compare its efficacy with a standard Nystatin ointment.
Phase 2 • Sponsor: Kerman University of Medical Sciences • Aim: Disease control
Last updated Aug 30, 2026 00:00 UTC
-
Could selenium boost kidney cancer treatment?
Disease control CompletedThis phase I trial studies the side effects and best dose of L-selenomethionine when given together with axitinib in treating patients with clear cell renal cell carcinoma that has spread from the primary site (place where it started) to other places in the body and usually canno…
Phase 1/2 • Sponsor: Mohammed Milhem • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Robot vs. therapist: which helps kids with CP walk better?
Symptom relief CompletedRobot assisted gait training is seen as a promising intervention for improving the walking abilities of children with cerebral palsy, but research to support its effectiveness compared to best practice physical therapy is lacking. This research consists of a randomized controlled…
Sponsor: University of Alberta • Aim: Symptom relief
Last updated Jun 27, 2026 12:29 UTC
-
New scan could reveal hidden cancer in High-Risk prostate patients
Knowledge-focused OngoingProstate cancer is the second most common malignancy worldwide and the fifth leading cause of male cancer-related mortality. Approximately 15% of localized cases are classified as high-risk for biochemical recurrence. These patients frequently harbour occult metastases undetected…
Sponsor: General University Hospital, Prague • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:37 UTC
-
New drug combo shows promise for genetic subtype of leukemia
Disease control OngoingThe purpose of this Phase I, multicenter, clinical trial is to evaluate the safety of AG-120 and AG-221 when given in combination with standard AML induction and consolidation therapy. The study plans to evaluate up to 2 dose levels of AG-120 in participants with an isocitrate de…
Phase 1 • Sponsor: Institut de Recherches Internationales Servier • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
New drug combo after transplant may keep myeloma at bay
Disease control CompletedThis phase II trial studies the safety of alternating ixazomib citrate and lenalidomide as treatment to help keep cancer from coming back after stem cell transplant (maintenance therapy) in treating patients with multiple myeloma. Ixazomib citrate may stop the growth of cancer ce…
Phase 2 • Sponsor: Fred Hutchinson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
Hunting for hidden genetic triggers of severe childhood epilepsy
Knowledge-focused Recruiting nowBrain somatic mutations are increasingly recognized as a major cause of focal epilepsies. These include mTOR pathway mutations underlying cortical malformations such as focal cortical dysplasia and hemimegalencephaly, and SLC35A2 mutations in MOGHE, and activating variants in the…
Sponsor: Fondation Ophtalmologique Adolphe de Rothschild • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:09 UTC
-
New pill aims to lift the fog of bipolar depression
Symptom relief CompletedThe study will evaluate the efficacy and safety of ITI-007 (Lumateperone) in patients diagnosed with Bipolar I or Bipolar II disorder having a major depressive episode. The study will be conducted in two parts, Part A and Part B. Part A is a randomized, double-blind, placebo-cont…
Phase 3 • Sponsor: Intra-Cellular Therapies, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 07:56 UTC